Cellular heterogeneity mediates inherent sensitivity-specificity tradeoff in cancer targeting by synthetic circuits

Mathieu Morel1, Roman Shtrahman2, Varda Rotter3

  • 1Department of Materials and Interfaces, Weizmann Institute of Science, Rehovot, Israel, 76100; Ecole Normale Supérieure, Paris Sciences et Lettres (PSL) Research University, Université Pierre et Marie Curie, CNRS, Département de Chimie, UMR 8640 PASTEUR, 75005 Paris, France; Université Pierre et Marie Curie Paris 06, École Normale Supérieure, CNRS, UMR 8640 PASTEUR, 75005 Paris, France;

Insights

Synthetic gene circuits offer precise cancer targeting. Researchers found a trade-off between specificity and sensitivity in these circuits, which can be tuned for better tumor cell killing.

Area of Science:

  • Synthetic biology
  • Molecular engineering
  • Cancer therapeutics

Background:

  • Synthetic gene circuits enable precise targeting of cancer cells by integrating multiple expression markers.
  • High sensitivity is crucial, as even minimal cancer cell escape can be detrimental.
  • Cellular variability in gene expression introduces errors in decision-making circuits, a factor previously unexplored.

Purpose of the Study:

  • To investigate the error rates and performance of synthetic gene circuits in heterogeneous cell populations.
  • To analyze the single-cell response function of a tunable logic AND gate.
  • To understand the inherent trade-offs between specificity and sensitivity in synthetic circuit design for cancer therapy.

Main Methods:

  • Measurement of the single-cell response function of a tunable logic AND gate operating on two promoters.
  • Utilizing heterogeneous cell populations to mimic real biological environments.
  • Implementation of a tumor-mimicking cell-culture model with cancer cells in a normal cell background.

Main Results:

  • An inherent trade-off between specificity and sensitivity was identified, governed by the AND gate's amplification gain and activation threshold.
  • Molecular parameters of synthetic circuits were shown to control specificity and sensitivity in a cancer cell killing assay.
  • The study quantifies the impact of cellular variability on synthetic circuit performance.

Conclusions:

  • Synthetic gene circuits can be optimized to target cancer cells with high specificity and sensitivity, despite inherent trade-offs.
  • Tuning molecular parameters of synthetic circuits is key to improving their efficacy in heterogeneous environments.
  • This research provides a framework for designing more effective synthetic gene circuit-based cancer therapies.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K